Acumen Pharmaceuticals, Inc. (ABOS)
ABOS Stock Price Chart
Explore Acumen Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ABOS price movements and trends.
ABOS Company Profile
Discover essential business fundamentals and corporate details for Acumen Pharmaceuticals, Inc. (ABOS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Jul 2021
Employees
61.00
Website
https://acumenpharm.comCEO
Daniel J. O'Connell
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
ABOS Financial Timeline
Browse a chronological timeline of Acumen Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.63.
Earnings released on 12 Aug 2025
EPS came in at -$0.68 falling short of the estimated -$0.54 by -25.93%.
Earnings released on 13 May 2025
EPS came in at -$0.48 surpassing the estimated -$0.56 by +14.29%.
Earnings released on 27 Mar 2025
EPS came in at -$0.62 falling short of the estimated -$0.47 by -31.91%.
Earnings released on 12 Nov 2024
EPS came in at -$0.50 falling short of the estimated -$0.36 by -38.89%.
Earnings released on 13 Aug 2024
EPS came in at -$0.34 falling short of the estimated -$0.28 by -21.43%.
Earnings released on 14 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%.
Earnings released on 26 Mar 2024
EPS came in at -$0.29 matching the estimated -$0.29, while revenue for the quarter reached $290.00K , missing expectations by -98.07%.
Earnings released on 13 Nov 2023
EPS came in at -$0.24 surpassing the estimated -$0.31 by +22.58%.
Earnings released on 8 Aug 2023
EPS came in at -$0.28 surpassing the estimated -$0.36 by +22.22%.
Earnings released on 9 May 2023
EPS came in at -$0.28 surpassing the estimated -$0.33 by +15.15%.
Earnings released on 27 Mar 2023
EPS came in at -$0.32 falling short of the estimated -$0.28 by -14.29%.
Earnings released on 14 Nov 2022
EPS came in at -$0.26 surpassing the estimated -$0.27 by +3.70%.
Earnings released on 15 Aug 2022
EPS came in at -$0.25 falling short of the estimated -$0.24 by -4.17%.
Earnings released on 16 May 2022
EPS came in at -$0.23 falling short of the estimated -$0.17 by -35.29%.
Earnings released on 28 Mar 2022
EPS came in at -$0.42 falling short of the estimated -$0.14 by -200.00%.
Earnings released on 15 Nov 2021
EPS came in at -$0.10 surpassing the estimated -$0.21 by +52.38%.
Earnings released on 16 Aug 2021
EPS came in at -$7.91 falling short of the estimated -$4.56 by -73.46%.
Earnings released on 2 Jul 2021
EPS came in at -$0.73 .
Earnings released on 31 Dec 2020
EPS came in at -$0.03 , while revenue for the quarter reached $1.44M .
Earnings released on 30 Sept 2020
EPS came in at -$0.09 , while revenue for the quarter reached $730.00K .
ABOS Stock Performance
Access detailed ABOS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.